Nick Orzano is Co-President and Principal, Pipeline Health System Principal, Stanton Road Capital, LLC where he works with healthcare and real estate private equity customers.
Rachael Vrooman is Director of Reconciliation and Financial Strategy for CVS/Caremark. She has held senior management positions with PinnacleRx Solutions, AmerisourceBergen, Apria Healthcare, and OptumRX.
Moze Cowper, recognized for his work with pharmaceutical and medical device companies, is the former lead counsel for Amgen, where his role included providing training and business advice to clients on negotiation of clinical trial agreements, consent forms, study protocols, and licensing deals.
Kay Stout Manovich has 30 years of experience in the strategic design business. She is a former managing director/chief brand strategist for Landor Associates, and founder of Kay Strategic Branding.
Kelly Chu has been leading technology initiatives in healthcare and other high-profile industries for more than 20 years. He is co-founder and CEO/CTO of Sierra Labs, a biotechnology company that automates compliance in regulated markets. Previously, he led the technology team at Science 37, a company focused on clinical research to rapidly accelerate biomedical discovery…
Kathy Freeman has managed teams within the CRO marketplace, and has strong relationships with key CRO industry leaders and clinical trial site operations. As executive director of Inspire, a leading health social network, she helps connect patients and caregivers, and find participants for clinical trials within their communities. She also served as vice president of…
John Neal brings extensive relationships in pharma, CRO, and clinical research sites to his role at MedVector. He is founder and chairman of PCRS Network, a group of independently owned and operated high quality, high enrolling Phase I, II, and III sites across the U.S. that conduct studies in a wide range of indications. He…
Craig Lipset designed and co-led the industry’s first fully virtual clinical trial, and continues to serve as a decentralized trials advisor to major pharmaceutical companies, as well as the Innovative Medicines Initiative in Europe. He is co-chair of the Decentralized Trials & Research Alliance, the largest non-profit collaboration advancing the global adoption of decentralized research,…
Ian Leaman is a sought-after expert on business planning and corporate finance. In addition to his role as CFO for MedVector, he is the founder of Duke & Leaman, a management consulting business based in Los Angeles, California. He also serves as CFO of Arkeytp, a company that links physical and digital solutions, and has…
Dr. Patterson is a senior hospital administrator turned entrepreneur, who has dramatically improved performance in some of the nation’s top hospitals and health systems. In addition to his role with MedVector, his seventh start-up, he is also a managing partner with Healthcare Advisors, and owner and chairman of Verras, Ltd. ─ three companies that are…
Ted Barduson has more than two decades of success leading operations, sales, and executive team management for transformative, industry-leading healthcare companies and start-ups. He has been instrumental in the growth of several healthcare companies which have led to a number of successful exits. As a visionary strategist specializing in sales and marketing team building, product…
Scott Stout has been recognized as one of the top healthcare innovators of 2021. While working as a professional investor in high-finance, Scott identified a large gap in the clinical trial marketplace and seized the opportunity to build a team of healthcare, high tech, and pharmaceutical experts to turn his concept of expanding clinical trials,…